Jamp India Pharmaceuticals Private Limited, a active foreign private limited company, was established on 20 November 2017 in Ahmedabad, Gujarat, India. Engaging in pharma contract r&d within the professional, scientific and technical sector, it holds CIN: U73100GJ2017FTC099869. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Employing 323 professional, Its leadership includes Alpeshkumar Thakkar (Director), Raveesh Grover (Director), David Dimeo (Director). Past directors included Alpeshkumar Thakkar, Nancy Baron, Francois Chouinard. Its latest AGM occurred on 25 September 2025, with the balance sheet filed on 31 March 2024. It is based at 1201 To 1204 & 1207 To 1212, 12Th Floor Navratna Corporate Park, Ambli Bopal Roa, D,, Ahmedabad, Gujarat, 380058.
U73100GJ2017FTC099869
099869
20 November 2017
₹0.10 M
₹0.10 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Jamp India Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Alpeshkumar Thakkar | Director | 30 Mar 2021 | Current |
| Raveesh Grover | Director | 20 Nov 2017 | Current |
| David Dimeo | Director | 27 Sep 2024 | Current |
| Marcandre Huot | Director | 27 Sep 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 24 Sep 2021 | Past |
| Pramod Abcsdd | Additional Director | 28 Sep 2018 | Past |
| Pramod Abcsdd | Director | 12 Jun 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Jamp India Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 43.96% increase. The company also saw a substantial fall in profitability, with a 45.95% decrease in profit. The company's net worth moved up by a moderate rise of 8.49%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Jamp India Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Jamp India Pharmaceuticals has a workforce of 323 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Jamp India Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jamp India Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Jamp India Pharmaceuticals Private Limited last Annual general meeting of members was held on 25 Sep 2025 as per latest MCA records. was completed.
David Dimeo was appointed as a Director was appointed as a Director on 27 Sep 2024 & has been associated with this company since 1 year 2 months . was recorded as a recent event.
Progress on Marcandre Huot was appointed as a Director was appointed as a Director on 27 Sep 2024 & has been associated with this company since 1 year 2 months . was documented.
Jamp India Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was recorded as a recent event.
Progress on Alpeshkumar Thakkar was appointed as a Director was appointed as a Director on 30 Mar 2021 & has been associated with this company since 4 years 8 months . was documented.
Progress on Raveesh Grover was appointed as a Director was appointed as a Director on 20 Nov 2017 & has been associated with this company since 8 years 1 month . was documented.
The CIN of Jamp India Pharmaceuticals Private Limited is U73100GJ2017FTC099869.
Jamp India Pharmaceuticals Private Limited is headquartered at 1201 To 1204 & 1207 To 1212, 12Th Floor Navratna Corporate Park, Ambli Bopal Roa, D,, Ahmedabad, Gujarat, 380058.
Jamp India Pharmaceuticals Private Limited was incorporated on 20 November 2017.
The current directors of Jamp India Pharmaceuticals Private Limited are
The primary industry of Jamp India Pharmaceuticals Private Limited is Professional, Scientific And Technical.
Jamp India Pharmaceuticals Private Limited is unlisted.
The authorized capital of Jamp India Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Jamp India Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX